Search research articles
Contact Us
Filters
Showing results (501-510 of 509) with videos related to
Page
of 51
Sort By:
You have reached the last page of results.
This site can display upto 509 results.
Biomedicine Hub
|
February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Reproductive Health
|
November 26, 2025
Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey
Giovanni Fulvio, Diana Marinello, Dina Zucchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pascal Pujol, Massimo Barberis, Philp Beer, et al.
JAMA Oncology
|
June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
Lucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Science (New York, N.Y.)
|
January 19, 2023
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Mandy L Ballinger, Swetansu Pattnaik, Piyushkumar A Mundra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Nature Communications
|
April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Page
of 51
Search research articles
Search
Showing results (501-510 of 509) with videos related to
Sort By:
Page
of 51
You have reached the last page of results.
This site can display upto 509 results.
Biomedicine Hub
|
February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology
Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Reproductive Health
|
November 26, 2025
Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey
Giovanni Fulvio, Diana Marinello, Dina Zucchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pascal Pujol, Massimo Barberis, Philp Beer, et al.
JAMA Oncology
|
June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
Lucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Science (New York, N.Y.)
|
January 19, 2023
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Mandy L Ballinger, Swetansu Pattnaik, Piyushkumar A Mundra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square
|
November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Dale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Nature Communications
|
April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Page
of 51